Shire-shifts-its-pipeline-towards-rare-illnesses
Shire shifts its pipeline towards rare illnesses
Shire successfully Acquires ViroPharma. This was one of the first steps in moving towards rare diseases....
Tags: ViroPharma, Shire Pharmaceuticals, rare diseases, ...
March 5, 2014
Abide-and-Celegne-co-operate
Abide and Celegne co-operate
Serine hydrolases researching company, Abide Therapeutics established a contribution with Celgene Corporation. They hope to develop new drugs for inflammation and immunology diseases...
Tags: Celegne Corporation, inflammation, Abide Therapuetics...
March 2, 2014
Forest-Labs-company-has-been-bought-hy-Actavis
Forest Labs company has been bought hy Actavis
Shareholders of Forest Labs got more than 25 billion dollars from Irish pharmaceutical company, Actavis. The portfolio which is to be purchased includes drugs such as Namenda....
Tags: Namenda, actavis ...
February 19, 2014
Servier-and-Curie-Cancer-institute-still-fight-together
Servier and Curie-Cancer institute still fight together
curie Cancer Center and Servier announced that they will renew their partnership and still fight agains breast cancer together. The two companies has been working together since 2005. ...
Tags: marie-curie, curie cancer, cancer, breast cancer...
February 13, 2014
Dramatic-job-cuts-at-Novartis
Dramatic job-cuts at Novartis
Novartis announced 500 Swiss job cuts. The company started to outsource a large part of its services to India. ...
Tags: novartis, india, jobcut, outsourcing...
February 6, 2014
Diabetes-Businnes-of-Bristol-Myers-was-sold-to-Astra-Zeneca
Diabetes Businnes of Bristol-Myers was sold to Astra-Zeneca
Bristol-Myers Squibb has already announced that is was going to sell its global diabetes businnes to AstraZeneca. The company now announced that the process is complete. AstraZeneca now has all the rights which were previously held by Bristol....
Tags: Bristol-Myers, Astra Zeneca, diabetes...
February 3, 2014
Girard-Gibbs-Announces-Class-Action-Lawsuit-on-Behalf-of-Investors-of-Immunomedics-Inc
Girard Gibbs Announces Class Action Lawsuit on Behalf of Investors of Immunomedics, Inc.
Girard Gibbs LLP, a company specialized in antibody based products announces that a class action lawsuit has been started on behalf of purchasers of Immunomedics, Inc....
Tags: Girard Gibbs, Lawsuit, Immunomedics...
March 2, 2014
Jubilant-Biosys-and-Janssen-is-going-to-expand-their-drug-discovery-deals
Jubilant Biosys and Janssen is going to expand their drug discovery deals
Jubilant and Janssen signed their contract in 2011. Jubilant delivered preclinical candidates to Janssen. The two companies no extract the contract on several therapeutic areas....
Tags: Janssen, Jubilant, preclinical...
February 22, 2014
Kerasali-Nail-is-going-to-be-introduced-in-Asia
Kerasali Nail is going to be introduced in Asia
Moberg Pharma and Menarini Asia-Pacific are to extend their collaboration and introduce Kerasali Nail in further parts of Asia. From the co-work they hope tohave huge profit on the nail fungus infection market. ...
Tags: Nail fungus, asia, kerasali nails, Menarini, moberg...
February 15, 2014
Merck-and-Samsung-are-to-develop-new-Diabetics-Drug
Merck and Samsung are to develop new Diabetics Drug
MK-1293, an insulin glargine candidate provides a good therapy for patients with diabetes type 1 and type 2. Merck and Samsung announced that they are going to collaborate over developing a more effective drug based on this component....
Tags: durg, diabetes, diabetes type 1, Merck, samsung...
February 13, 2014
Ablynx-and-Merck-are-collaborating
Ablynx and Merck are collaborating
Ablynx is forming a colaboration wioth Merck to develop immunology drugs. The new partnership is focusing on predefined nanobody candidates and so called immun checkpoint modulators. ...
Tags: immune checkpoint modulators, immune, ablynx, Merck...
February 6, 2014
Lilly-Paharmaceuticals-az-Pfizer-share-the-cost-of-major-researches
Lilly Paharmaceuticals az Pfizer share the cost of major researches.
Tanezumab is a pain-reliever being developed by Lilly pharmaceuticals. The company announced that it has signed a 1,8 billion dollar agreement with Pfizer to help the development....
Tags: tanezumab, Lilly, research, contirbution. ...
January 31, 2014
MOST VIEWED

HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013